The countries that would have the most need for open therapeutics platforms are likely those with limited access to healthcare, high disease burden, and insufficient resources to develop and implement their own therapeutic solutions. Some of these countries include: Low-income countries in sub-Saharan Africa, such as Malawi, Mozambique, and Sierra Leone, which struggle with inadequate healthcare infrastructure and limited access to essential medicines. Countries with high disease burden, such as India, Nigeria, and Pakistan, which face significant challenges in managing communicable diseases like tuberculosis, malaria, and HIV/AIDS. Countries with vulnerable populations, such as Yemen, Syria, and Ukraine, which are affected by conflict, displacement, and humanitarian crises, leading to increased healthcare needs. Countries with emerging economies, such as Brazil, Indonesia, and South Africa, which may have growing healthcare needs due to rapid urbanization and changing disease patterns.These countries may benefit from open therapeutics platforms that provide access to affordable medicines, innovative treatment solutions, and collaborative research opportunities to address their unique healthcare challenges.